We propose a method for extracting physics-based biomarkers from a single multiparametric Magnetic Resonance Imaging (mpMRI) scan bearing a glioma tumor. We account for mass effect, the deformation of brain parenchyma due to the growing tumor, which on its own is an important radiographic feature but its automatic quantification remains an open problem. In particular, we calibrate a partial differential equation (PDE) tumor growth model that captures mass effect, parameterized by a single scalar parameter, tumor proliferation, migration, while localizing the tumor initiation site. The single-scan calibration problem is severely ill-posed because the precancerous, healthy, brain anatomy is unknown. To address the ill-posedness, we introduce an ensemble inversion scheme that uses a number of normal subject brain templates as proxies for the healthy precancer subject anatomy. We verify our solver on a synthetic dataset and perform a retrospective analysis on a clinical dataset of 216 glioblastoma (GBM) patients. We analyze the reconstructions using our calibrated biophysical model and demonstrate that our solver provides both global and local quantitative measures of tumor biophysics and mass effect. We further highlight the improved performance in model calibration through the inclusion of mass effect in tumor growth models-including mass effect in the model leads to 10% increase in average dice coefficients for patients with significant mass effect. We further evaluate our model by introducing novel biophysics-based features and using them for survival analysis. Our preliminary analysis suggests that including such features can improve patient stratification and survival prediction.Index Terms-tumor growth model personalization, inverse problem, mass effect, glioblastoma (Preprint submitted to IEEE Transactions on Medical Imaging)
I. INTRODUCTIONComputational oncology is an emerging field that attempts to integrate biophysical models with imaging with the goal of assisting image analysis in a clinical setting. Typically, the integration is accomplished by calibrating PDE model parameters from images. A significant challenge in brain tumors, and in particular, GBMs, is the single-scan calibration, that becomes even harder in the presence of mass effect. However, modeling provides the capability for automatic quantification of mass effect along with additional biomarkers related to